Fortis Healthcare on Monday said it is exploring legal means with respect to the Supreme Court judgment that found the company guilty of contempt for violating the court's earlier order
Daiichi Sankyo case: SC holds former Ranbaxy promoters Malvinder, Shivinder Singh guilty of contempt of court
The Supreme Court on Friday held former Ranbaxy promoters Malvinder Singh and Shivinder Singh guilty of contempt of court for violating its order asking them not to divest their shares in Fortis Healthcare Limited
Daiichi-Ranbaxy case: Radha Soami chief claims in Delhi High Court don't owe money to Singh brothers
Radha Soami Satsang Beas (RSSB) head Gurinder Singh Dhillon and his family members on Friday approached the Delhi High Court saying they do not owe any money to RHC Holdings Pvt Ltd, promoted by Malvinder and Shivinder Singh
Ranbaxy promoters Malvinder, Shivinder Singh diverted funds despite order to maintain stakes, Daiichi Sankyo tells SC
The Supreme Court had earlier expressed displeasure at the replies of Malvinder and Shivinder to its directive to submit a plan for paying Rs 4,000 crore to Daiichi Sankyo, as awarded by a Singapore tribunal.
Miffed at replies of ex-Ranbaxy promoters, Supreme Court to hear Daiichi's contempt plea against them
Miffed at replies of former Ranbaxy promoters Malvinder and Shivinder Singh to its directive to submit a plan for paying Rs 4,000 crore to Daiichi Sankyo, as awarded by a Singapore tribunal, the Supreme Court on Friday threatened to send them to jail if found that they have violated the apex court's order
SC asks Malvinder Singh and Shivinder Singh to submit concrete plan for paying Rs 3,500 cr to Daiichi Sankyo
The Supreme Court on Thursday asked former Ranbaxy promoters Malvinder Singh and Shivinder Singh to submit a concrete plan for paying Rs 3,500 crore to Daiichi Sankyo as directed by a Singapore tribunal
Firstpost Editor's Picks: Jadhav case at ICJ, Pulwama aftermath, Gully Boy's failings; today's must-read stories
A quick rundown of five of the best articles published by Firstpost on Monday, 18 February
Singh brothers' feud is a wake-up call for corporate governance in dysfunctional family-run companies
The Singh brothers have lost control of two listed companies — Fortis Healthcare and Religare Enterprises — in less than a decade.
Creation of jobs, improving judicial adjudication, and bringing in foreign investment to remain concerns in 2019
Leather and beef industries were major employers in the country, and even while new jobs could not be created, existing jobs were being jeopardized.
Sebi may reopen an insider trading case against Sun Pharma and as well as probe alleged lapses by some of its promoters and other entities in raising funds overseas..
Former Fortis and Ranbaxy promoters Malvinder Singh and Shivinder Mohan reportedly came to blows in the latest turn to their ongoing feud.
Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi
Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance
Daiichi Sankyo, which has filed an intervention application in the insolvency plea filed by HDFC Bank, said they have a decree to recover money against RHC Holding.
Fortis spat: Shivinder Singh says filing lawsuit against Malvinder, Sunil Godhwani was 'long overdue'; full text of letter
The spat between the Singh brothers -- Malvinder, Shivinder, who are also co-promoters of the beleagured Fortis Health Care has come out in the open
Fortis Healthcare on Wednesday said its shareholders have voted in favour of removal of Brian Tempest from the Board of Directors
True tech power comes from harvesting patents: ISRO, Cipla and Biocon show the way for future entrepreneurs
Is there an entrepreneur out there who has the money and the audacity to gamble on a new future? India could do with some audacious private entrepreneurs.
Daiichi writes to ED: Singh brothers of Ranbaxy fame formed companies of ‘dubious nature’ to siphon off money
Daaichi is awaiting to get an arbitration award of Rs 3,500 from Singh brothers who according to the company did not reveal full details of Ranbaxy at the time of selling it to Daiichi.
Kulbhushan Jadhav case at ICJ in the Hague: All you need to know about India's representative Harish Salve
The International Court of Justice at the Hague in the Netherlands suspended the death sentence against the alleged spy Kulbhushan Jadhav. Jadhav was given a death sentence by a Pakistani military court on 10 April on the charges of espionage and waging war against Islamabad.
Daiichi had filed an arbitration case alleging the Singh brothers concealed and misrepresented information when they sold their Ranbaxy stake
The transaction is subject to approval from the Competition Commission of India and other customary closing conditions